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Abstract
Bacterial cell growth and division require coordinated cell wall hydrolysis and synthesis, allowing for the removal and
expansion of cell wall material. Without proper coordination, unchecked hydrolysis can result in cell lysis. How these
opposing activities are simultaneously regulated is poorly understood. In Mycobacterium tuberculosis, the resuscitation-
promoting factor B (RpfB), a lytic transglycosylase, interacts and synergizes with Rpf-interacting protein A (RipA), an
endopeptidase, to hydrolyze peptidoglycan. However, it remains unclear what governs this synergy and how it is
coordinated with cell wall synthesis. Here we identify the bifunctional peptidoglycan-synthesizing enzyme, penicillin
binding protein 1 (PBP1), as a RipA-interacting protein. PBP1, like RipA, localizes both at the poles and septa of dividing cells.
Depletion of the ponA1 gene, encoding PBP1 in M. smegmatis, results in a severe growth defect and abnormally shaped
cells, indicating that PBP1 is necessary for viability and cell wall stability. Finally, PBP1 inhibits the synergistic hydrolysis of
peptidoglycan by the RipA-RpfB complex in vitro. These data reveal a post-translational mechanism for regulating cell wall
hydrolysis and synthesis through protein–protein interactions between enzymes with antagonistic functions.
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Introduction
Mycobacterium tuberculosis, the causative agent of tuberculosis, kills
approximately two million people each year and remains dormant
within an estimated one-third of the world’s population [1]. M.
tuberculosis has the remarkable ability to survive extended periods of
time under stressful conditions within the host, only to reactivate,
grow, and cause a relapse into active disease [2]. Reactivation
likely relies upon the ability of mycobacteria to regulate the
expansion and remodeling of cell wall material, an essential yet
poorly understood bacterial process. Because cell wall biology is a
rich area for antibiotic development, elucidating the mechanisms
of essential cell wall processes in mycobacteria offers new avenues
for chemotherapy targeted to actively growing or reactivating
bacteria. Mycobacteria possess basic cell wall remodeling require-
ments similar to other bacteria, such that understanding
mycobacterial cell wall homeostasis may provide new insights into
universal paradigms of cell wall regulation.
One such highly conserved area of cell wall remodeling is the
need for regulation of peptidoglycan synthesis and degradation.
Peptidoglycan (PG) is found in nearly all bacteria and is responsible
for giving bacteria their shape and structural integrity [3,4].
Escherichia coli PG is composed of polysaccharides containing
repeating disaccharide subunits of N-acetyl glucosamine and N-
acetyl muramic acid, while mycobacterial PG contains N-acetyl
glucosamine and a mixture of N-glycolyl muramic acid and N-
acetylmuramicacid [5]. Thesepolymersarecross-linkedbypeptide
bridges into a rigid three-dimensional lattice known as a sacculus.
PG elongation requires a suite of enzymes with both synthetic and
hydrolytic activities. Bifunctional penicillin binding proteins (PBPs)
possess both transglycosylase and transpeptidase domains that
covalently incorporate newly synthesized PG polymers into the
existing sacculus. To accomplish this in E. coli, hydrolytic enzymes
with lytic transglycosylase and endopeptidase specificity are thought
to first remove old PG monomers from the cell wall before
incorporation of a new three-unit PG polymer [6]. Little is known
about how mycobacteria expand and degrade their septal and polar
PG. While it is useful to consider how other bacteriametabolizePG,
it has yet to be shown if these models hold true for mycobacteria.
The coordination of PG synthases and hydrolases (also known
as autolysins) is critical for growth and division, as well as
maintenance of cellular structural integrity. Thus, a mechanism
for controlling cell wall hydrolases must exist, yet the molecular
details of this process are not well defined. Protein-protein
interactions are potentially a central element of autolysin
homeostasis, since binding partners can inhibit, sequester, or
activate other proteins. Multiple interactions have been found
between PG synthetic and hydrolytic enzymes in Haemophilus
influenzae and E. coli, leading to the hypothesis that these
remodeling enzymes may exist as holoenzyme complexes in vivo
[7,8,9]. Despite these biochemical characterizations, the functional
consequence of these interactions remains largely unknown.
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remodeling is poorly understood. Recent work in mycobacteria
proposes a PBP3-FtsW-FtsZ complex that regulates the initiation
of septation, but little is known how PG synthesis and hydrolysis
are coordinated during this event [10]. We have previously shown
that the Mycobacterium tuberculosis endopeptidase RipA (Rv1477)
interacts with a lytic transglycosylase, RpfB, at the septum of
dividing cells [11]. This interaction positively regulates PG
hydrolysis since the RipA-RpfB complex synergistically degrades
PG in vitro [12]. Since RipA is essential for division in M. smegmatis
and M. tuberculosis [12,13], this endopeptidase is an attractive target
for studying regulation of cell wall homeostasis. While the
interaction of RipA and RpfB appears to be functionally
important, it is unclear how two enzymes that both degrade PG
could, by themselves, regulate PG metabolism. To this end, we
investigated how additional protein-protein interactions may
modulate RipA function.
Here, we identify the mycobacterial bifunctional PG synthesiz-
ing enzyme, penicillin-binding protein 1 (PBP1), as a regulator of
RipA-RpfB PG hydrolase activity. We report that PBP1 interacts
with RipA in a yeast two-hybrid assay and co-precipitates with
RipA. PBP1 localizes to the poles and septa, the sites of PG
synthesis in mycobacteria and depletion of the PBP1 gene, ponA1,
from mycobacteria results in the cessation of growth and
formation of abnormally shaped, structurally compromised cells.
Finally, PBP1 inhibits the synergistic hydrolysis of PG by the
RipA-RpfB complex. Together, these data support a model where
PBP1 restrains RipA-RpfB cell wall degradation in mycobacteria
through a novel protein-protein interaction between antagonistic
proteins.
Results
Yeast two-hybrid screen using M. tuberculosis RipA
identifies PBP1
RipA was previously identified through a screen for mycobac-
terial proteins that interact with RpfB, and was shown to be a PG
hydrolase necessary for cell division [11,12]. We hypothesized that
additional factors may interact with and regulate the activity of
RipA during coordinated cell division and growth. Therefore, we
conducted a yeast two-hybrid screen to identify novel RipA
interacting proteins.
A translational fusion was made between the C-terminal 123
amino acids of M. tuberculosis RipA (Figure 1A) and the GAL4
DNA binding domain (BD-RipA), and screened against a random
library of M. tuberculosis genomic fragments translationally fused to
the GAL4 activation domain (AD). Approximately 1610
6
independent clones were screened for interaction with RipA by
histidine prototrophy and b-galactosidase activity. Potential
interactors were counterscreened for non-specific interactions
and evaluated by quantitative b-galactosidase assays. From this
screen, we identified a region encoding the C-terminal 259 amino
acids of penicillin-binding protein 1 (PBP1) that interacts with
RipA (Figure 1B).
Mycobacterial PBP1 and RipA interact at their C-terminal
domains
Mycobacterial PBP1 is a high molecular weight, class A,
penicillin-binding protein [14]. The N-terminus of PBP1 contains
a noncleavable signal sequence by which PBP1 is translocated
across and anchored to the plasma membrane [14]. The N-
terminus also contains a transglycosylase domain homologous to
the E. coli PBP1 [15] and is responsible for ligating N-glycolyl
muramic acid from existing PG sacculus to N-acetyl glucosamine
from lipid II PG precursor monomers (Figure 1B). The C-terminus
of mycobacterial PBP1 contains a penicillin binding transpeptidase
domain homologous to the E. coli PBP1 [15] that crosslinks D-
alanine to the dibasic amino acid D-meso-diaminopimelic acid
(DAP) between two parallel strands of PG.
To determine the interaction domains of mycobacterial PBP1
and RipA, we mapped the interacting regions of each protein
using the yeast two-hybrid system. Four overlapping regions of 200
amino acids each of PBP1 were assayed for interaction with the C-
terminal 123 amino acids of RipA. Of the constructs tested, only
the construct containing the C-terminal 259 amino acids of PBP1
was sufficient for interaction with RipA, while constructs lacking
the C-terminal 150 amino acids failed to interact (Figure 2A). This
interacting region contains two-thirds of the transpeptidase
domain of PBP1.
In concert, we created and tested several RipA deletion
constructs for interaction with the C-terminal 259 amino acids
of PBP1 in the yeast two-hybrid assay. Deletion of the extreme C-
terminus of RipA abrogated the interaction (Figure 2B, lanes 2&3),
while the C-terminal 25 amino acids of RipA were sufficient for
binding PBP1 (Figure 2B, lane 5). This region is adjacent to the
predicted endopeptidase domain of RipA and, interestingly, has
been shown to bind RpfB [11]. These results demonstrate that
RipA and PBP1 interact at the domains that are responsible for
cleaving and forming, respectively, the crosslinks between PG
strands. Since the RipA interaction domain also binds the PG
hydrolase domain of RpfB, PBP1 and RpfB may participate in
concert to regulate septal PG remodeling.
Mycobacterial PBP1 and RipA coprecipitate
To confirm the specific interaction of RipA and PBP1, we
performed an in vitro co-precipitation assay. Translational fusions
of the C-terminal 259 amino acids of M. tuberculosis PBP1 with
glutathione-S-transferase (GST), as well as the C-terminal 283
amino acids of M. tuberculosis RipA with maltose-binding protein
(MBP) were constructed. E. coli co-expressing either GST and
MBP-RipA or GST-PBP1 and MBP-RipA were lysed, and GST
Author Summary
Bacteria have a complex problem to solve. On one hand,
they need to hydrolyze existing and synthesize new cell
wall to allow for cell expansion during growth. On the
other hand, they need to maintain a continuous layer of
cell wall to preserve shape and protect from osmotic lysis.
To do this, bacteria must tightly coordinate the processes
of cell wall hydrolysis and synthesis. How these opposing
activities are simultaneously regulated is poorly under-
stood. We previously demonstrated the interaction be-
tween two cell wall hydrolytic proteins, RpfB and RipA, in
mycobacteria. This RpfB-RipA complex resulted in en-
hanced hydrolysis of cell wall, suggesting protein–protein
interactions as one mechanism for regulating hydrolysis.
However, what regulates interactions of these potentially
lethal enzymes and what coordinates hydrolysis with
synthesis remains unknown. To investigate this question,
we screened for mycobacterial proteins that interact with,
and thus potentially regulate, RipA. Here, we report the
interaction of RipA with PBP1, a cell-wall-synthesizing
enzyme. Depletion of PBP1 from mycobacteria results in
misshapen cells and impaired growth. Moreover, we find
that PBP1 inhibits the synergistic activity of the RipA-RpfB
interaction. These data reveal a mechanism for coordinat-
ing cell wall hydrolysis and synthesis through interactions
between antagonistic enzymes.
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Co-purifying proteins were detected by Western blotting with an
anti-MBP antibody (top panel). Coomassie Blue-staining demon-
strated that the amounts of GST (middle panel) and MBP
available were similar (bottom panel). We observed that MBP-
RipA is only detected when GST-PBP1 was present. These results
demonstrate that RipA co-purifies specifically with PBP1, and has
no detectable interaction with GST (Figure 3A) despite precipi-
tating the same amount of recombinant GST. To control for the
amount of protein available for interaction and precipitation,
GST-PBP1, GST, and MBP-RipA were expressed separately and
purified. GST and MBP-RipA or GST-PBP1 and MBP-RipA
were mixed in equimolar amounts, incubated, and MBP tagged
proteins precipitated with amylose resin. Co-purifying proteins
were detected by Western blotting with an anti-GST antibody.
Again we observed that similar amounts of GST (middle panel)
and MBP (bottom panel) were purified using Coomassie Blue
staining. We found that GST-PBP1 co-purified with MBP-RipA,
but GST alone did not (Figure 3B). Taken together, this work
demonstrates that RipA and PBP1 specifically interact in vivo in
bacteria, in vitro, and in a yeast two-hybrid system.
PBP1 localizes to the poles and septa of mycobacteria
In most other bacteria, PG synthesizing proteins, including
PBPs, localize to the septum and/or lateral cell walls, indicating a
role in septal and/or lateral wall PG synthesis, respectively
[16,17,18]. To determine where PBP1 regulates PG remodeling,
we assessed its localization in vivo. M. tuberculosis PBP1 was fused at
its C-terminus to monomeric red fluorescent protein (RFP) and
expressed under the control of a tetracycline-inducible promoter.
We found that M. tuberculosis PBP1-RFP predominantly localized
to the poles of M. smegmatis (the site of cell growth in mycobacteria)
and occasionally at the septa of dividing cells (Figure 4). PBP1-
RFP was not toxic, as cells expressing the protein exhibited normal
morphology and growth (data not shown). Uninduced PBP1-RFP
yielded no detectable fluorescence and RFP alone remained
diffuse and cytosolic, with no observable bands of localization
(data not shown), demonstrating that the PBP1-RFP signal is
specific. Thus, PBP1 localizes to the poles and septa of
mycobacteria, in contrast to the septal-only localization described
for B. subtilis [18,19]. This finding is consistent with evidence
indicating that mycobacteria grow from their tips [20,21].
Depletion of mycobacterial PBP1 blocks normal cell
division
Given its localization in vivo, it is likely that PBP1 is involved in
both elongation and septation. Strains of E. coli with both ponA1
homologues deleted are nonviable [22] and null strains of ponA1
homologues in the actinobacterium C. glutamicum are defective for
elongation and septation [23]. To determine the functional role of
PBP1 in mycobacteria, we constructed a conditional depletion
strain in M. smegmatis, where transcription of the genes encoding
PBP1 (MSMEG6900) and its operon (Figure S1) are activated by
an inducible tetracycline promoter (Figure 5A). Since we
hypothesized that PBP1 is involved in PG synthesis and cell
division, we expected that depletion of PBP1 should yield changes
in morphology and/or viability.
When the conditional PBP1 depletion strain was grown in the
absence of inducer, we observed a dramatic growth defect
(Figure 5B). The PBP1 conditional strain grew normally in the
presence of inducer and was impaired for growth in the absence of
inducer in a dose-dependent manner. Due to the high selective
Figure 1. M. tuberculosis RipA identifies bifunctional synthase PBP1. (A) RipA, a 472 residue protein, contains a domain of unknown function
(COG3883) as well as a predicted endopeptidase domain. The region used to screen for interacting proteins in a yeast two-hybrid screen is shown,
consisting of amino acids 350–472. (B) PBP1, a 678 residue protein encoded by ponA1, is a bifunctional peptidoglycan synthase. PBP1 contains a
transglycosylase domain at the N-terminus and a penicillin-sensitive transpeptidase domain at the C-terminus.
doi:10.1371/journal.ppat.1001020.g001
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appeared to recover and grow at late time points (Figure 5B).
However, this was due to escape from repression, as cells from
these late time points were no longer depleted for ponA1
transcription (Figure S2). The observed growth defect correlated
with gross morphological changes. PBP1-operon depletion led to
single, short, unseptated cells, suggesting that PBP1 functions in
both elongation and septation. Furthermore, these cells possessed
bulbous regions, commonly at their ends (Figure 5C, arrows),
which is indicative of increased cell wall hydrolysis and loss of
structural and morphological integrity. This is consistent with a
model of cell wall regulation by PG synthase-hydrolase complexes.
To confirm that the growth defect and morphological
abnormalities observed under conditions lacking inducer were
specifically due to PBP1 depletion (as opposed to polar effects on
the downstream genes in the operon), we complemented the PBP1
Figure 2. C-terminal regions are required for interaction. (A) Data from quantitative LacZ assays of four overlapping regions of 200 amino
acids each of PBP1 tested for interaction with the C-terminal 123 amino acids of RipA. The C-terminal 259 amino acids of PBP1 were found to be
sufficient for interaction with RipA, while regions lacking the C-terminal 150 amino acids failed to interact. Data shown are from a representative
experiment done in triplicate. Data are represented as mean +/2 SEM. (B) Data from quantitative LacZ assays of several different deletion constructs
for interaction with the C-terminal 259 amino acids of PBP1 in the yeast two-hybrid assay. Deletion of the C-terminal of RipA decreased the intensity
of interaction and the C-terminal 25 amino acids of RipA were sufficient for interaction with PBP1. Data shown are from a representative experiment
done in triplicate. Data are represented as mean +/2 SEM.
doi:10.1371/journal.ppat.1001020.g002
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purified directly from the lysate. Co-purifying MBP fusion proteins were detected by Western blotting using anti-MBP antibody (top panel). Unfused
GST was used to test the specificity of the interaction. A Coomassie-stained PAGE gel containing lysates obtained prior to GST purification (bottom
panel) and after GST purification (middle panel) is shown to demonstrate that similar amounts of proteins were available for pulldown. (B) Proteins
were separately purified from E. coli, combined as indicated in equimolar amounts, incubated, then purified on amylose resin. Samples were taken
before (middle and bottom panels) and after (top panel) MBP purification. A Coomassie-stained PAGE gel containing protein mixtures prior to MBP
purification is shown to demonstrate that similar amounts of proteins were available for pulldown. Co-purifying GST fusion proteins were detected by
Western blotting using anti-GST antibody. Unfused GST was used to test the specificity of the interaction.
doi:10.1371/journal.ppat.1001020.g003
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promoter expressing M. smegmatis PBP1 or an empty vector. Both
constructs contain the gene encoding red fluorescent protein (RFP)
as a control for expression from the complementation plasmid. As
shown in Figure 6A & B, the PBP1 depletion strain does not grow
in the absence of inducer unless a plasmid producing PBP1 is
provided in trans. This complementation also applies to the
observed morphological defect. When the conditional mutant is
complemented with PBP1 and grown in the absence of inducer,
the cells are morphologically identical to cells of the conditional
mutant without the complementing plasmid grown in the presence
of inducer (Figure 6C). Both strains produced RFP, demonstrating
that PBP1 is expressed off the complementation vector.
PBP1 inhibits the synergistic hydrolysis of cell wall by
RipA and RpfB
RipA can hydrolyze peptidoglycan as shown in studies using
a variety of FITC-labeled, cell wall-derived substrates [12].
RipA hydrolytic activity is augmented in the presence of RpfB.
Given that RipA binds PBP1 with the same domain sufficient
Figure 4. PBP1 localizes to the poles and septa of M. smegmatis. Fluorescence microscopy of M. smegmatis expressing M. tuberculosis PBP1
fused to monomeric red fluorescent protein (RFP). PBP1-RFP fusion protein is under the control of a tetracycline-inducible promoter. PBP1 localized
to the poles and also to septa. Arrows indicate narrow septa where PBP1 does not localize and arrowheads indicate larger septa where PBP1 localizes.
doi:10.1371/journal.ppat.1001020.g004
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affects the PG hydrolytic activity of RipA alone or in complex
with RpfB.
We expressed and purified PBP1, RipA, and RpfB as GST
fusion proteins in E. coli, and incubated various combinations of
these enzymes with several FITC-labeled cell wall-derived
substrates. Confirming our previous results, RipA, but not GST
alone, was able to hydrolyze peptidoglycan purified from
Streptomyces, a substrate that structurally resembles PG derived
from mycobacteria. Furthermore, synergistic hydrolysis was
observed when RpfB was combined with RipA, as previously
shown [12]. However, addition of PBP1 to a reaction containing
both RipA and RpfB inhibited this synergy, resulting in activity
levels at or below that of RipA alone (Figure 7A, B). The activity of
RipA combined with PBP1 was similar to that of RipA alone,
suggesting that the PBP1 interaction does not affect the
endogenous activity of RipA, but rather modulates the hydrolytic
potential of the RipA-RpfB complex. As expected, PBP1 alone did
Figure 5. Depletion of PBP1 blocks cell division. (A) Diagram showing the strategy used to replace the native promoter of the ponA1 operon
(PponA1) in M. smegmatis with a tetracycline-inducible promoter (Ptet) through homologous recombination (strategy and diagram adapted from
[12]). OriE: E. coli origin of replication. (B) PBP1 (ponA1) depletion strain of M. smegmatis was grown with inducer (ATC=anhydrotetracycline), then
inoculated into media with decreasing amounts of inducer and followed by OD600 over time. Data are represented as mean +/2 standard deviation.
(C) Micrographs of M. smegmatis PBP1 (ponA1) depletion strain with membranes imaged by staining with TMA-DPH. Bacteria were grown with no
anhydrotetracycline inducer (No ATC), 10, or 100 ng/ml ATC. Bacteria grown with 100 ng/ml ATC grew as wildtype, while No ATC and 10 ng/ml ATC
grew slowly, with bulbous poles and round-shaped regions (indicated by white arrows). Bacteria were visualized with a 1006objective.
doi:10.1371/journal.ppat.1001020.g005
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of PBP1 to RpfB. These results demonstrate that PBP1 is able to
modulate cell wall hydrolytic activity by inhibiting the synergistic
interaction between RpfB and RipA.
Discussion
How new peptidoglycan is coordinately synthesized and
hydrolyzed during bacterial growth and division is not well
Figure 6. M. smegmatis ponA1 complements ponA1 operon depletion. (A) The M. smegmatis ponA1 depletion strain was complemented with
either a vector expressing an operon of M. smegmatis ponA1 and red fluorescent protein (RFP) or RFP alone. Complemented strains were grown in the
presence (50 ng/ml ATC) or absence of inducer and growth was determined by OD600. While the RFP complemented strain only grew in the presence
of inducer, the PBP1 complemented strain grew normally in both the absence and presence of inducer. (B) At 36 hours post-induction, cultures from
RFP and ponA1 complemented strains were photographed. Data is representative of several biological replicates for both strains. (C) Microscopic
analysis of complemented strains—either the RFP complemented strain grown with inducer or the ponA1 complemented strain without inducer—
showed that both strains expressed RFP from the complementation vector and appear morphologically normal.
doi:10.1371/journal.ppat.1001020.g006
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hydrolases and synthases working in a spatially and temporally
coordinated manner. During cell division in mycobacteria, a thick
layer of septal PG is initially synthesized between the two daughter
cells before being digested by hydrolases. This results in two new
poles on separate daughter cells [24,25]. Likewise during cell
elongation, existing PG is thought to be hydrolyzed to allow new
PG subunits to be incorporated. While little is known about how
mycobacteria regulate these events, some general concepts can be
gleaned from other bacteria. In E. coli and H. influenzae, evidence
suggests that there are PG-synthesizing and degrading complexes
assembled for PG elongation and midcell septation in bacteria
[7,8,26]. For instance, PBP1B interacts with MltA, a lytic
transglycosylase, and MipA, a structural protein [8], comprising
part of a theorized larger complex. These data and other studies
identifying complexes containing PG-synthesis enzymes [7,8,26]
strengthen the concept that PG-remodeling holoenzymes exist and
may consist of as much as four enzymatic domains including
Figure 7. PBP1 inhibits the synergistic hydrolysis of cell wall by RipA-RpfB complex. N-terminal GST fusion proteins were expressed and
purified from E. coli. Equal amounts of individual or combinations of proteins were incubated with insoluble FITC-labeled substrate: M. luteus cell wall
material (A) or Streptomyces peptidoglycan (B). The extent of hydrolysis was determined by measuring the amount of soluble FITC remaining after
centrifugation, and thus released during hydrolysis of the insoluble substrate. GST and buffer alone were used to determine background release of
FITC and were subtracted from final values. Data are from representative experiments, each done in triplicate. Data are represented as mean +/2
SEM. p-values for one-tailed, unpaired t-tests: (A) 1 vs. 2: 0.027 significant, 2 vs. 4: 0.016 significant, 1 vs. 3: 0.074 not significant, 1 vs. 4: 0.188 not
significant, (B): 1 vs. 2: 0.009 significant, 2 vs. 4: 0.018 significant, 1 vs. 3: 0.279 not significant, 1 vs. 4: 0.240 not significant (significant to p,0.05). (C)
Schematic diagram of the basic structure of mycobacterial peptidoglycan, indicating where RpfB and RipA are predicted to have hydrolytic activity
and where PBP1 is predicted to have synthetic activity. Lines connecting NAG to NGM represent b-1,4-glycosidic bonds, while lines connecting NGM
to NGM represent peptide cross-linkages. NAG: N-acetyl glucosamine, NGM: N-glycolyl muramic acid, NAM: N-acetyl muramic acid (note that
mycobacteria have a mixture of NGM and NAM, with the NGM structure shown here).
doi:10.1371/journal.ppat.1001020.g007
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and lytic transglycosylase, activities. A complex of these four
functions should be sufficient to insert and remove PG monomers
during elongation or septation in E. coli [27,28]; however, no
report to date has identified this theoretical complex in any
bacteria. Here we demonstrate the interaction of three mycobac-
terial proteins – RpfB, RipA and PBP1 – containing a
combination of domains that fulfills the four theoretically
necessary reactions for PG remodeling.
Recently, functional data has emerged to show that protein-
protein interactions between PG modifying enzymes can modulate
PG hydrolytic or synthetic activity. We have previously shown that
the interaction between the lytic transglycosylase RpfB and the
endopeptidase RipA of mycobacteria leads to synergistic PG
hydrolytic activity in vitro [12]. Similarly, increased PG synthesis is
observed in vitro by the interaction of the E. coli PG synthase
PBP1B and the structural cell division protein FtsN [29]. Despite
these advances in understanding how individual interactions affect
PG remodeling, a mechanism for the regulated coordination
between PG hydrolytic and synthetic processes, which must occur
in vivo, has only been theorized. In support of this theory,
inactivation of PBPs with penicillin treatment in pneumococcus
rapidly leads to unchecked murein hydrolase activity and bacterial
lysis [30]. Furthermore, overexpression of a catalytically inactive
PBP1B in E. coli leads to lysis of the bacterium [31], suggesting the
presence of a PBP1 protein complex capable of controlling
autolysin activity. Here we report the novel interaction between
the M. tuberculosis PG hydrolase RipA and the PG synthase PBP1.
This RipA-PBP1 interaction not only provides three of the four
necessary PG remodeling activities, but also regulates PG
remodeling by antagonizing the synergistic hydrolytic activity of
the RipA-RpfB interaction. Molecularly, this is consistent with the
predicted sites of action of the two hydrolases and the bonds
catalyzed by PBP1 (Figure 7C).
There are several possibilities for how PBP1 could inhibit RipA-
RpfB synergy. Given that both PBP1 and RpfB bind RipA, the
most likely scenario is competition between PBP1 and RpfB for
binding to RipA. Because we find that RipA interacts with PBP1
at the same C terminal 25 amino acids of RipA required for RpfB
binding, PBP1 could displace RpfB. This would explain the in vitro
antagonism between RpfB and PBP1 for activating hydrolytic
activity. Furthermore, these interactions might help coordinate
septal PG synthesis and division in vivo as shown in Figure 8. In this
model, PBP1 might complex with RipA and inhibit PG hydrolysis
sufficiently to allow septal PG synthesis. When septal PG is fully
synthesized, RpfB may compete with PBP1 for binding to RipA,
leading to the formation of a highly effective PG hydrolysis
complex and the coordinated degradation of septal PG during
separation of daughter cells.
PG hydrolysis experiments reported here were conducted with
M. luteus and Streptococcus PG, demonstrating a general ability for
the enzymes to regulate degradation of several types of PG.
However, the regulation of mycobacterial PG degradation in vivo is
likely to be more complex. Our assays for PG hydrolysis are
admittedly imperfect. Events that must occur in minutes or hours
in the cell require days to detect. In part, this is due to the non-
physiological conditions in the assay systems. Activity might be
affected by modifications to either the enzymes or the structure of
peptidoglycan. In fact, the functional interactions we observe likely
represent only a small portion of the regulatory interactions in the
cell wall, which probably include other proteins as well as
modifications of enzymes and their substrates.
Because of its localization at the septum and poles in the
actinobacterium C. glutamicum, PBP1 is thought to be responsible
for synthesis of both septal and polar PG [17,18,19,23,32]. To
evaluate whether PBP1 functions similarly in mycobacteria, we
sought to determine the localization of PBP1 in vivo. We find that
PBP1-RFP localizes to the poles and septa in mycobacteria, the
two primary sites of PG synthesis in mycobacteria, suggesting that
PBP1 functions in both elongation and septation. It is possible that
the C-terminal RFP fusion affects localization of PBP1. However,
RipA also localizes to both the poles and septum of mycobacteria
[11] and C-terminally tagged RipA remains functional (not
shown).
PBP1 plays a critical role in PG synthesis and viability across
divergent bacterial species. Depletion of the PBP1 paralogues in C.
glutamicum results in defects in PG elongation and division [23].
Likewise, in E. coli, the similar PBP1A and PBP1B proteins are
each dispensable for growth, but deletion of both genes is lethal,
with defects in both cell elongation and septation [33]. Disruption
of ponA1 in M. smegmatis was previously shown to result in
decreased growth and hypersensitivity to b-lactams antibiotics
[34]. Clearly, in this published work, PBP1 could be disrupted and
cells continued to grow. Methodological differences could account
for the phenotype we see. Isolated mutants are under strong
selective pressure and might easily develop compensatory
mutations that permit growth. In the case of PBP1, for example,
this might be due to overexpression of another PBP with partially
overlapping function. In our system, cells are not under selective
pressure until inducer is removed and cannot rapidly adapt to the
loss of the enzyme. However, selective pressure is strong enough to
rapidly select for strains that produce PBP1 even in the absence of
inducer (Figure 2SA), again suggesting that loss of PBP1 is highly
deleterious.
When PBP1 was provided in trans, the depletion strain grew like
wildtype, implicating the importance of PBP1 in the depleted
operon. Cells that express decreased amounts of PBP1 are small
and abnormally shaped, consistent with the notion that PBP1 is
involved in both elongation and septation. The bulging seen in
these cells phenocopies the morphology of penicillin-treated
bacteria prior to autolysin-dependent lysis [35]. This abnormal
morphology is characteristic of increased and/or dysregulated PG
hydrolytic activity, leading to a loss of structural integrity. This
phenotype is predicted by our model, in which PBP1 is necessary
for regulating PG hydrolysis, in part by restraining RipA from
synergizing with RpfB (and possibly with other autolysins).
Finally, it is plausible that protein-protein interactions between
different PG remodeling enzymes within cell wall complexes are
universal molecular mechanisms for coordinating the different
growth states of bacteria. While this work has begun to define the
role of these interactions during cell division, this mechanism of
action may extend beyond exponential growth. Could mycobac-
teria use similar regulatory systems for other growth conditions
such as reactivation of dormant cells from dormancy? In B. subtilis,
regrowth from a spore, or germination, involves several division
machinery genes, including DivIVA (a MinCD regulator and
chromosome partitioner protein) [36] and PrkC (a Ser/Thr
protein kinase) [37]. Interestingly, mycobacterial homologues of
these genes, wag31 and pknB, respectively, are key regulators of
division and morphology during vegetative growth [38,39], and
may serve a dual function during resuscitation of mycobacteria. Of
note, the Rpf PG hydrolase family of proteins appears necessary
for mycobacterial resuscitation from dormancy in vitro
[40,41,42,43,44] and survival in vivo [45,46,47]. Given the
interaction between RipA and RpfB and their synergistic function
in septal PG remodeling, the Rpf proteins may represent another
example of enzymes that play different biological roles during
different growth states. Understanding the molecular mechanism
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homeostasis may inform us on how cells can transition between
physiological states.
Materials and Methods
Strains and culture conditions
E. coli XL-1 (Stratagene) strains were used for cloning and were
grown at 37uC in Luria-Bertani (LB) broth or agar and
supplemented with kanamycin (50 mg/ml), ampicillin (100 mg/
ml), hygromycin (100 mg/ml) or zeocin (25 mg/mL) when
appropriate. E. coli BL21 (DE3) (Stratagene) was used for
production of recombinant proteins from the pET41a (Novagen)
or pMal (New England Biolabs) vectors for GST or MBP fusions,
respectively. Mycobacterium smegmatis (mc
2155) was grown at 37uC
in Middlebrook 7H9 broth supplemented with ADC (albumin-
dextrose-catalase) and 0.05% Tween80 and kanamycin (25 mg/
ml) or hygromycin (50 mg/ml) when appropriate. Saccharomyces
cerevisiae strains PJ69–4A (MATA trp1–901 leu2–3,112 ura3–52his3–
200 gal4 gal80 LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ) was
grown at 30uC in appropriate selective media and transformed
according to the Clontech Matchmaker manual or using the Zymo
EZ Kit (Zymo Research).
Yeast two-hybrid screen
We fused DNA encoding the C-terminal 123 amino acids of the
M. tuberculosis allele of RipA to DNA encoding the yeast GAL4
DNA binding domain (BD-RipA) in the pAS4 vector (similar to
pAS2, but with a uracil marker rather than tryptophan) and
screened against a random library of M. tuberculosis gene fragments
fused to DNA encoding the GAL4 activation domain (AD) using
the Matchmaker System (Clontech) as previously published [48].
Interactions were required to grow on plates lacking histidine or
adenine and produce b-galactosidase. Potential candidates were
tested for nonspecific interaction with the human Lamin protein.
Further mapping of interacting regions was conducted similarly,
but with known gene fragments. Growth was determined by
visualizing the density of growth on selective plates and was
categorized as ‘+++’ (strong), ‘++’ (moderate), ‘+’ (minimal, but
evident), and ‘–’ (lacking).
Figure 8. Model of RipA regulation by PBP1 during septation. A RipA-PBP1 complex that exists at the initiation of septation may synthesize a
thick layer of peptidoglycan (PG) between daughter cells during the process of cytokinesis. After PG synthesis and fission are finished, RipA may
exchange PBP1 for autolysin binding partners like RpfB. These new complexes are highly efficient at PG hydrolysis and will separate the cell walls of
the two mature daughter cells.
doi:10.1371/journal.ppat.1001020.g008
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Three independent cultures of each yeast strain were assayed for
b-galactosidase activity using ONPG (o-Nitrophenyl-beta-D-Ga-
lactopyranoside) as substrate, according to the Clontech Match-
maker manual.
Recombinant protein production
DNA encoding the C-terminal 283 amino acids of RipA was
cloned into the pMal-C2X MBP expression vector (New England
Biolabs) as well as the pET41a GST expression vector, while DNA
encoding the 259 amino acids of the C-terminal of PBP1 or DNA
encoding the 70 amino acid conserved region of RpfB was cloned
into the pET41a GST expression vector (Novagen). The E. coli
expression strain, BL21(DE3) was used to synthesize each protein
following the Novagen manual protocol. Protein concentrations
were measured using the Bradford assay, normalized, and
confirmed by Coomassie Blue-stained polyacrylamide gels.
Co-precipitation assay
DNA encoding the C terminal 259 amino acid portion of M.
tuberculosis PBP1 was cloned into pET41a to create a GST fusion.
DNA encoding the C terminal 283 amino acids of M. tuberculosis
RipA were cloned into the pMalC2x vector to create a MBP
fusion. Bl21 E. coli were co-transformed with both PBP1 and RipA
fusion plasmids. As a control, the RipA-MBP plasmid was also co-
transformed with an empty pET41a GST plasmid. Cells were
grown to an OD of 0.5, induced with 1mM IPTG at 30uC for
3 hours and lysed by sonication for 10 seconds, 15 cycles in
HEPES lysis buffer (25 mM HEPES, 50 mM KCl, 5mM MgCl2,
pH 7.5). Recombinant GST fusion proteins were precipitated with
Glutathione Sepharose 4B resin (Amersham Biosciences) for
1 hour at 4uC, rotating. The resin was then washed 3 times
with cold 16 PBS +1% Triton X-100. Recombinant +and co-
precipitating proteins were eluted with glutathione elution buffer
(10mM reduced glutathione, 50mM Tris-HCl, pH 8.0) at 25uC,
15 minutes. Also, equimolar amounts of purified and normalized
GST or GST-PBP1 proteins were combined with equimolar
amounts of normalized MBP or MBP-RipA proteins in 1.5 ml
tubes containing 500 ml PBS. The protein mixture was gently
rocked at 4uC for 4 to 15 hours. Before further purification, 60 ml
of mixture was removed and saved as a loading control. From the
remaining mixture, MBP proteins were purified using amylose
resin or GST proteins were purified using sepharose (New
England Biolabs) as per directions. Co-purifying proteins and
loading controls were detected using immunoblotting with a GST
or MBP polyclonal antibody at 1:10,000 dilution.
Immunoblotting
Protein samples were combined with 46Laemmli’s SDS PAGE
buffer and boiled at 100uC for 5 minutes. Proteins were separated
on 8% Tris-tricine polyacrylamide gels by electrophoresis,
transferred to nitrocellulose, and probed with anti-sera against
MBP (New England Biolabs) or GST using standard techniques.
Preparation and FITC-labeling of cell wall material
Streptomyces peptidoglycan and lyophilized M. luteus cell wall were
both obtained from Sigma. The fluorescein isothiocyanate (FITC)-
labeled bacterial cell wall was prepared by covalently linking FITC
to amine groups in the cell wall. 10 mg FITC (Molecular Probes)
was used to label 10 mg of insoluble peptidoglycan or cell wall
material following the protocol from Protocols in Protein Science
(adapted from Molecular Probe notes).
Enzyme assay
Recombinant M. tuberculosis proteins were incubated with
several FITC-labeled cell wall substrates and assayed for activity
by measuring FITC release. 25mg of Rpf, PBP1 or RipA alone or
in various combinations, was added to 25 ml of 2 mg/ml substrate
and 25 ml4 6reaction buffer (50 mM Tris, 10mM MgCl, 50 mM
KCl, 2mM MnCl, 0.01% Chaps, 100 mM KH2PO4, pH 5.75).
The final volume was brought to 100 ml with H2O. Similar
combinations with GST were also tested. GST alone, as well as
buffer alone, was used to determine background release of FITC.
After incubating at 30uC with enzyme and buffer for 3–5 days, the
insoluble substrate was centrifuged (5 minutes at 18,0006g) and
soluble FITC remaining in the supernatant was measured with
filters for excitation 485 nm and emission 538 nm. Significance
was determined using one-tailed, unpaired t-tests using Prism
software.
Generation of depletion strains
The depletion strain was generated as previously described
[12,49]. Briefly, M. smegmatis, with the tetracycline repressor gene
integrated into the attB site, was transformed in the presence of
anhydrotetracylcine with a suicide vector containing the first 600
nucleotides of M. smegmatis ponA1 gene under control of the
tetracycline operator/promoter system (Ptet). Transformants were
selected for hygromycin resistance. Appropriate recombination
was confirmed using forward primers to Ptet and PponA1 (native
ponA1 promoter) paired with a reverse primer to the 39 end of
ponA1. The presence of a product of appropriate size for the
former and lacking in the latter, confirmed the desired strain.
Depletion strain growth
The ponA1 (PBP1) depletion strain was initially grown in 7H9
media containing kanamycin (selecting for TetR) and hygromycin
(selecting for inserted pTet) as well as anhydrotetracycline (ATC).
Once cultures reached late log-phase or stationary phase, they
were centrifuged (25006g for 5 minutes), washed once with PBS,
and resuspended in media with varying amounts of ATC.
Complementation analysis
M. smegmatis ponA1 was synthesized by Genscript (Piscataway,
NJ) and cloned under the control of the M. tuberculosis GroEL2
promoter. Monomeric RFP was cloned into the complementation
vector alone or downstream of ponA1, as a control to confirm
expression from this promoter. Complementation vectors express-
ing RFP alone or PBP1 with RFP were electroporated into the
ponA1 depletion strain and transformants selected on hygromycin,
kanamycin and zeocin supplemented with 100ng/mL ATC.
Complemented strains were grown in 7H9 with 100 ng/mL
ATC until log phase, and then diluted to an OD of approximately
0.0002 and grown in media containing various concentrations of
ATC.
Real time PCR
M. smegmatis strains were grown with either 50 ng/mL or no
anhydrotetracycline and all samples were collected at mid log
phase. ponA1 expression was measured using the following primers:
59 GGAGGCATCAAGGCGTACTA; 59 AACACCTTGA-
ACGACGAACC.
ponA1 levels were normalized to sigA expression, which was
measured using the following primers:
59 AAGACACCGACCTGGAACTC; 59 AGCTTCTTCT-
TCCTCGTCCTC.
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protocol in the RNA Protect Bacteria Reagent handbook (Qiagen,
Valencia, CA) and cell pellets stored at 280C. Disruption was
achieved with three, 1 minute beadbeating cycles. RNA was
isolated using the RNeasy Mini Kit (Qiagen), but with an
additional DNAse treatment on the column before elution and a
second DNAse digestion with Turbo DNase according to
manufacturer’s instructions (Ambion, Foster City, CA). Reverse
transcription of the RNA was carried out using the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems, Foster
City, CA). Quantitative PCR utilized Power SyBr green PCR
master mix (Applied Biosystems) and reactions were run and
analyzed on a Step One Plus real time system (Applied
Biosystems).
Microscopy and imaging
M. smegmatis strains were centrifuged at 25006g for 2 minutes,
washed with 1ml PBS, and resuspended in 20 ml of PBS containing
50mM TMA-DPH for staining membranes. Samples were imaged
using a Nikon TE-200E microscope with a 1006 (NA 1.4)
objective and captured with an Orca-II ER cooled CCD camera
(Hamamatsu, Japan). Shutter and image acquisition were
controlled using Metamorph Software (Molecular Devices). Final
images were prepared using Adobe Photoshop 7.0.
Supporting Information
Figure S1 Diagram of ponA1 and ponA2 operons. ponA1 (rv0050
of M. tuberculosis and MSMEG6900 of M. smegmatis), is the first
gene in an operon with two other genes of unknown function.
rv0051 (MSMEG6899) encodes a conserved transmembrane
protein with 24% identity to GPI mannosyl-transferase with a
DXD motif common in glycosyltransferases that utilize nucleotide
sugars and rv0052 (MSMEG6898) encodes a conserved hypothet-
ical protein. There are two paralogues of ponA in both M.
tuberculosis and M. smegmatis, ponA1 and ponA2, similar to other
bacteria. ponA2 (rv3682)o fM. tuberculosis encodes the first gene in a
predicted operon with two other genes. rv3863 encodes a
conserved secreted phosphohydrolase, possibly involved in histi-
dine biosynthesis. rv3684 encodes a protein with homology to
cysteine synthases. Arrows in black represent encoding genes of
the ponA predicted operon, while grey arrows represent the next
encoding gene on either side of the operon.
Found at: doi:10.1371/journal.ppat.1001020.s001 (0.49 MB TIF)
Figure S2 PBP1 depletion strain escape from regulation (A)
Growth of the PBP1 depletion strain was analyzed by optical
density in the presence and absence of the inducer, anhydrote-
tracycline (ATC). (B) ponA1 expression was analyzed by RT-PCR
in PBP1 depletion strains grown in the presence of inducer (50 ng/
ml ATC) and in three independent cultures grown without inducer
(no ATC). The no ATC cultures began to grow at late time points
(,50 hours). All four strains were taken at mid exponential phase
for PBP1 transcript analysis and normalized by sigA levels.
Found at: doi:10.1371/journal.ppat.1001020.s002 (0.27 MB TIF)
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